HomeBlogBlogDiabetes Treatment Denied in Pennsylvania
March 1, 2026
🛡️
ClaimBack Editorial Team
Insurance appeal specialists · Regulatory research team · How we verify accuracy

Diabetes Treatment Denied in Pennsylvania

Insurance denied your diabetes treatment in Pennsylvania? Learn about insulin caps, CGM rights, Medicaid coverage, and how to appeal effectively.

Pennsylvania is home to more than 1.3 million adults with diagnosed diabetes, and insurance denials for diabetes-related treatments remain a significant barrier to care across the state. Whether you are on a commercial plan through a major insurer, enrolled in Medicaid, or covered by a Medicare Advantage plan, Pennsylvania law provides meaningful rights when your coverage is denied — and a clear path to fight back.

🛡️
Was your insurance claim denied?
Get a professional appeal letter in 3 minutes — citing real regulations for your country and insurer.
Start My Free Appeal →Free analysis · No login required

The Pennsylvania Insurance Landscape for Diabetes

Pennsylvania's top health insurers include Highmark Blue Cross Blue Shield, Independence Blue Cross, Geisinger Health Plan, UPMC Health Plan, Aetna, and UnitedHealthcare. The state's insurance market is anchored by regional players like Highmark and Independence, which have significant market share in western and eastern Pennsylvania respectively. The Pennie marketplace serves those seeking individual ACA-compliant plans.

Pennsylvania's Insurance Department regulates fully insured plans and enforces state mandates. Federal law governs self-funded ERISA employer plans, which are common among the state's large manufacturing, education, and healthcare employers.

Pennsylvania's Insulin Cost-Cap Law

Pennsylvania enacted an insulin cost-cap law capping monthly out-of-pocket costs for insulin at $35 per 30-day supply for patients on state-regulated plans. If you are enrolled in a qualifying plan and paying above this amount, report this to the Pennsylvania Insurance Department at 1-877-881-6388.

Medicaid (PA Medicaid / HealthChoices) and Diabetes

Pennsylvania's Medicaid program runs through the HealthChoices managed care system. Medicaid covers insulin, oral diabetes medications, blood glucose monitors, test strips, and CGMs (subject to Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization). Insulin pumps are also covered for eligible patients, typically requiring documentation of Type 1 diabetes or a specific clinical need.

If your HealthChoices plan denied a CGM or GLP-1 medication, you have the right to a grievance process within the MCO and, if that fails, a Fair Hearing before the Pennsylvania Department of Human Services (DHS). Request a Fair Hearing by contacting the DHS Bureau of Hearings and Appeals at 1-800-799-7773.

Common Denials in Pennsylvania

GLP-1 Drugs (Ozempic, Mounjaro, Trulicity, Rybelsus): Highmark and Independence BlueCross impose prior authorization requirements for GLP-1 agonists, often requiring documented failure of metformin and one additional agent. When Ozempic is prescribed for weight management co-morbid with diabetes, insurers may deny it citing the obesity indication. Ensure your physician codes the diabetes indication clearly (E11.xx) on all prescriptions and prior authorization requests.

CGMs: Denials for Type 2 patients not using insulin are common. The most effective response is a physician letter citing the ADA's 2024 recommendation for CGM use in Type 2 patients using basal insulin, and the documented incidence of hypoglycemia.

Time-sensitive: appeal deadlines are real.
Most insurers require appeals within 30–180 days of denial. After that, you lose your right to contest. Start your free appeal now →

Insulin Pumps: UPMC Health Plan and Highmark commonly require failure of MDI therapy to be documented over a set period (typically 3-6 months). An endocrinologist's letter explaining why pump therapy is clinically superior for this patient is essential.

Fighting a denied claim?
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →

Formulary Tier Issues: Newer diabetes medications like Jardiance, Farxiga, or Victoza may be on non-preferred tiers, resulting in high cost-sharing that effectively functions as a denial. Request a formulary exception citing the clinical evidence for the specific medication over the preferred alternatives.

How to Appeal a Diabetes Denial in Pennsylvania

  1. Obtain your denial letter and request the plan's specific medical necessity criteria and clinical guidelines used in the decision.
  2. Have your physician write a letter of medical necessity citing ADA guidelines, your clinical history, A1C readings, and why the denied treatment is appropriate.
  3. File an internal grievance/appeal. Pennsylvania requires insurers to resolve standard appeals within 30 days and expedited appeals within 72 hours.
  4. Request External Independent Review: Complete Guide" class="auto-link">external review through the Pennsylvania Insurance Department if your internal appeal fails. External review is conducted by an IROs) Explained" class="auto-link">independent review organization (IRO) and is binding on the insurer.
  5. File a complaint with the Pennsylvania Insurance Department at insurance.pa.gov or 1-877-881-6388.

For ERISA-governed employer plans, your appeals rights are federal, and you can contact the U.S. Department of Labor's EBSA at 1-866-444-3272.

State Insurance Department Contact

Pennsylvania Insurance Department (PID)

  • Consumer Services Phone: 1-877-881-6388
  • Website: insurance.pa.gov

Pennsylvania Department of Human Services (DHS — Medicaid fair hearings)

  • Phone: 1-800-799-7773
  • Website: dhs.pa.gov

Additional Resources

The American Diabetes Association (diabetes.org) provides appeal templates and advocacy support for Pennsylvania patients. The Pennsylvania Health Law Project (phlp.org) offers free legal assistance for individuals navigating Medicaid coverage disputes and is a particularly valuable resource for low-income patients.

Pennsylvania's external review process is accessible and free to patients, and external reviewers frequently disagree with the insurer's medical necessity determinations. Get your physician involved early, document your clinical history thoroughly, and file your appeal promptly.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

💰

How much did your insurer deny?

Enter your denied claim amount to see what you could recover.

$
📋
Get the free appeal checklist
The 12-point checklist that helped ~60% of appealed claims get overturned.
Free · No spam · Unsubscribe any time
40–83% of appeals win. Yours could too.

Your insurer is counting on you giving up.

Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.

We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.

Free analysis · No credit card · Takes 3 minutes

More from ClaimBack

ClaimBack helps you fight denied insurance claims with appeal letters built on AI and data from thousands of real denials. Start your free analysis — it takes 3 minutes.